Cite
HARVARD Citation
Dores, G. et al. (2021). Adverse events reported to the U.S. Food and Drug Administration Adverse Event Reporting System for tisagenlecleucel. American journal of hematology. 96 (9), pp. 1087-1100. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Dores, G. et al. (2021). Adverse events reported to the U.S. Food and Drug Administration Adverse Event Reporting System for tisagenlecleucel. American journal of hematology. 96 (9), pp. 1087-1100. [Online].